HeteroSight, which stems from CHUV, is developing an AI tool that reveals on a standard biopsy slide whether a tumour contains several genetically distinct zones. The project has received a FIT-InnoTREK grant of CHF 100,000 to build a first cohort and validate its model.
- Announced on
- Round
- Grant
- Amount
- CHF 100,000
- Sector
- Health & medtech
Investors
- FIT Vaud (Innovaud) lead
Preparing a similar round?
The diagnostic shows you the instruments and investors that fit your stage.
Start the diagnostic